Long-term outcome of preoperative transarterial chemoembolization and hepatic resection in patients with hepatocellular carcinoma
1
조회
0
다운로드
0
인용
0
참고문헌
초록
Background/Aims: Transarterial chemoembolization (TACE) improves the survival of patients with unresectable hepatocellular carcinoma (HCC) and has been recommended as a first-line therapy for nonsurgical patients with large or multifocal HCC. The long-term outcome of HCC patients receiving TACE prior to hepatic resection is uncertain. Methods: Between January 1997 and December 2007, 1,530 patients underwent hepatic resection for HCC at our center. Thirty-two patients received 1~12 sessions of TACE followed by surgical resection (TACE-surgery group). Their overall and recurrence-free survival rates were compared with those of 64 age- and sex-matched controls who underwent surgery only (surgery group). Overall and recurrence-free survival rates were analyzed. Results: The 1-, 2-, and 5-year overall survival rates did not differ significantly between the TACE-surgery group and the surgery group (78%, 60%, and 26%, respectively, vs. 97%, 83%, and 45%, respectively; P=0.11); however, the 1-, 2-, and 5-year recurrence-free survival rates were significantly lower in the TACE-surgery group than in the surgery group (58%, 36%, and 7%, respectively, vs. 77%, 58%, and 32%, respectively; P=0.01). The distribution of recurrence sites in the TACE-surgery group were intrahepatic in 85.7% and extrahepatic in 14.3%, and did not differ from those in the surgery group (91.4% and 8.6%, respectively; P=0.66). Conclusions: HCC patients who underwent TACE before resection appear to have overall survival rates that are comparable to those without preoperative therapy, although recurrence rates appear to be higher in patients with TACE.
Abstract
Background/Aims: Transarterial chemoembolization (TACE) improves the survival of patients with unresectable hepatocellular carcinoma (HCC) and has been recommended as a first-line therapy for nonsurgical patients with large or multifocal HCC. The long-term outcome of HCC patients receiving TACE prior to hepatic resection is uncertain. Methods: Between January 1997 and December 2007, 1,530 patients underwent hepatic resection for HCC at our center. Thirty-two patients received 1~12 sessions of TACE followed by surgical resection (TACE-surgery group). Their overall and recurrence-free survival rates were compared with those of 64 age- and sex-matched controls who underwent surgery only (surgery group). Overall and recurrence-free survival rates were analyzed. Results: The 1-, 2-, and 5-year overall survival rates did not differ significantly between the TACE-surgery group and the surgery group (78%, 60%, and 26%, respectively, vs. 97%, 83%, and 45%, respectively; P=0.11); however, the 1-, 2-, and 5-year recurrence-free survival rates were significantly lower in the TACE-surgery group than in the surgery group (58%, 36%, and 7%, respectively, vs. 77%, 58%, and 32%, respectively; P=0.01). The distribution of recurrence sites in the TACE-surgery group were intrahepatic in 85.7% and extrahepatic in 14.3%, and did not differ from those in the surgery group (91.4% and 8.6%, respectively; P=0.66). Conclusions: HCC patients who underwent TACE before resection appear to have overall survival rates that are comparable to those without preoperative therapy, although recurrence rates appear to be higher in patients with TACE.
참고문헌 (26)
- Parkin DM, "Estimating the world cancer burden: Globocan 2000", Int J Cancer, 94, pp.153~156 (2001)
- Llovet JM, "Hepatocellular carcinoma", Lancet, 362, pp.1907~1917 (2003)
- Sugioka A, "hepatocellular carcinoma", Surgery, 113, pp.612~618 (1993)
- Liver Cancer Study Group of Japan, "Primary liver cancer in Japan in Clinicopathologic features and results of surgical treatment", Ann Surg, 211, pp.277~287 (1990)
- Choi TK, "Results of surgical resection for hepatocellular carcinoma", Hepatogastroenterology, 37, pp.172~175 (1990)
- Nagorney DM, "Primary hepatic malignancy: surgical management and determinants of survival", Surgery, 106, pp.740~748 (1989)
- Paquet KJ, "Limited hepatic resection for selected cirrhotic patients with hepatocellular or cholangiocellular carcinoma: a prospective study", Br J Surg, 78, pp.459~462 (1991)
- Bruix J, "Chemoembolization for hepatocellular carcinoma", Gastroenterology, 127(1), pp.S179~188 (2004)
- Lau WY, "Transarterial chemoembolization for hepatocellular carcinoma", J Am Coll Surg, 202, pp.155~168 (2006)
- Bruix J, "Management of hepatocellular carcinoma", Hepatology, 42, pp.1208~1236 (2005)
- Yu YQ, "Experience with liver resection after hepatic arterial chemoembolization for hepatocellular carcinoma", Cancer, 71, pp.62~65 (1993)
- Fan J, "Improved survival with resection after transcatheter arterial chemoembolization (TACE) for unresectable hepatocellular carcinoma", Dig Surg, 15, pp.674~678 (1998)
- Majno PE, "Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis", Ann Surg, 226, pp.688~701 (1997)
- Ochiai T, "Hepatectomy with chemoembolization for treatment of hepatocellular carcinoma", Hepatogastroenterology, 50, pp.750~755 (2003)
- Lu CD, "Preoperative transcatheter arterial chemoembolization and prognosis of patients with hepatocellular carcinomas: retrospective analysis of 120 cases", World J Surg, 23, pp.293~300 (1999)
- Sugo H, "Role of preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: relation between postoperative course and the pattern of tumor recurrence", World J Surg, 27, pp.1295~1299 (2003)
- Wu CC, "Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal", Br J Surg, 82, pp.122~126 (1995)
- Uchida M, "Role of preoperative transcatheter arterial oily chemoembolization for resectable hepatocellular carcinoma", World J Surg, 20, pp.326~331 (1996)
- Sasaki A, "Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma", Eur J Surg Oncol, 32, pp.773~779 (2006)
- Korean Liver Cancer Study Group and National Cancer Center, Korea, "Practice guidelines for management of hepatocellular carcinoma 2009", Korean J Hepatol, 15, pp.391~423 (2009)
- The Korean Liver Cancer Study Group, "The General Rules for the Study of Primary Liver Cancer. 2nd ed", pp.1~56 (2004), Sunmungak
- Nagasue N, "Adverse effects of preoperative hepatic artery chemoembolization for resectable hepatocellular carcinoma: a retrospective comparison of 138 liver resections", Surgery, 106, pp.81~86 (1989)
- onfil RD, "Tumor necrosis can facilitate the appearance of metastases", Clin Exp Metastasis, 6, pp.121~129 (1988)
- Lee YT, "Primary liver cancer: pattern of metastasis", J Surg Oncol, 36, pp.26~31 (1987)
- Liou TC, "Pulmonary metastasis of hepatocellular carcinoma associated with transarterial chemoembolization", J Hepatol, 23, pp.563~568 (1995)
- Yamasaki S, "A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma", Jpn J Cancer Res, 87, pp.206~211 (1996)